Updated Guidance by the CDC and FDA for Prescribing Opioids – June 2023
Post date: July 14, 2023/ Pharmacy Announcements
- Maximize the use of nonopioid therapies when possible and only consider opioids if the benefits of therapy are expected to outweigh the risks. Many nonopioid therapies (including nonpharmacological interventions) are at least as effective as opioids for common types of acute pain.
- Before starting opioids for pain, establish realistic treatment goals and discuss a plan for discontinuation if the expected benefit is not realized.
- If opioid therapy is indicated, an immediate-release product is preferred. Reserve long-acting or extended-release opioids for severe, continuous pain.
- When opioids are initiated in opioid-naïve individuals with acute, subacute, or chronic pain, prescribe the lowest effective dosage for no longer than the expected duration of pain severe enough to require opioids. Evaluate the potential benefits and risks when considering an increase in dose.
